Succinylation and redox status in cancer cells
Succinylation is a post-translational modification (PTM) event that associates metabolic reprogramming with various pathological disorders including cancers via transferring a succinyl group to a residue of the target protein in an enzymic or non-enzymic manner. With our incremental knowledge on the...
Main Authors: | Xiaofeng Dai, Yanyan Zhou, Fei Han, Jitian Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1081712/full |
Similar Items
-
Protein succinylation: regulating metabolism and beyond
by: Xiaoli Hou, et al.
Published: (2024-02-01) -
Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers
by: Xiaofeng Dai, et al.
Published: (2022-12-01) -
Lysine succinylation and SIRT5 couple nutritional status to glutamine catabolism
by: Michael J. Lukey, et al.
Published: (2020-05-01) -
Lysine succinylation, the metabolic bridge between cancer and immunity
by: Rui Shen, et al.
Published: (2023-11-01) -
Alteration of mitochondrial protein succinylation against cellular oxidative stress in cancer
by: Jing Zhang, et al.
Published: (2022-02-01)